Former AXA Framlington Biotechnology fund manager Andy Smith has joined biopharma specialist Mann Bioinvest to launch an income-focused fund in the coming weeks.
The Magna BioPharma Income fund, slated to launch around the end of Q1 2013, will be managed by Smith, with key decisions overseen by an investment committee. Boutique equity house Charlemagne Capital...
One of two new partners appointed by firm
Latest news and analysis
Quarterly trading update
Set up Vanguard in 1975
Claimed to be taking action on climate change